Population deworming every 6 months with albendazole in 1 million pre-school children in north India: DEVTA, a cluster-randomised trial

Abstract

SummaryBackgroundIn north India many pre-school children are underweight, many have intestinal worms, and 2–3% die at ages 1·0–6·0 years. We used the state-wide Integrated Child Development Service (ICDS) infrastructure to help to assess any effects of regular deworming on mortality.MethodsParticipants in this cluster-randomised study were children in catchment areas of 8338 ICDS-staffed village child-care centres (under-5 population 1 million) in 72 administrative blocks. Groups of four neighbouring blocks were cluster-randomly allocated in Oxford between 6-monthly vitamin A (retinol capsule of 200 000 IU retinyl acetate in oil, to be cut and dripped into the child's mouth every 6 months), albendazole (400 mg tablet every 6 months), both, or neither (open control). Analyses of albendazole effects are by block (36 vs 36 clusters). The study spanned 5 calendar years, with 11 6-monthly mass-treatment days for all children then aged 6–72 months. Annually, one centre per block was randomly selected and visited by a study team 1–5 months after any trial deworming to sample faeces (for presence of worm eggs, reliably assessed only after mid-study), weigh children, and interview caregivers. Separately, all 8338 centres were visited every 6 months to monitor pre-school deaths (100 000 visits, 25 000 deaths at age 1·0–6·0 years [the primary outcome]). This trial is registered at ClinicalTrials.gov, NCT00222547.FindingsEstimated compliance with 6-monthly albendazole was 86%. Among 2589 versus 2576 children surveyed during the second half of the study, nematode egg prevalence was 16% versus 36%, and most infection was light. After at least 2 years of treatment, weight at ages 3·0–6·0 years (standardised to age 4·0 years, 50% male) was 12·72 kg albendazole versus 12·68 kg control (difference 0·04 kg, 95% CI −0·14 to 0·21, p=0·66). Comparing the 36 albendazole-allocated versus 36 control blocks in analyses of the primary outcome, deaths per child-care centre at ages 1·0–6·0 years during the 5-year study were 3·00 (SE 0·07) albendazole versus 3·16 (SE 0·09) control, difference 0·16 (SE 0·11, mortality ratio 0·95, 95% CI 0·89 to 1·02, p=0·16), suggesting absolute risks of dying between ages 1·0 and 6·0 years of roughly 2·5% albendazole versus 2·6% control. No specific cause of death was significantly affected.InterpretationExisting ICDS village staff can be organised to deliver simple pre-school interventions sustainably for many years at low cost, but regular deworming had little effect on mortality in this lightly infected pre-school population.FundingUK Medical Research Council, USAID, World Bank (albendazole donated by GlaxoSmithKline).

Practices and outcomes of self-treatment with helminths based on physicians' observations

“…However, the largest randomized trial performed in human history to date (Awasthi et al, 2013) addressed the question of the 'toxicity' of helminths in a quantitative way. Covering approximately 5 million human life years, the trial evaluated the effect of de-worming on the mortality and weight of children in northern India.…”

Effect of Deworming on Indices of Health, Cognition, and Education Among Schoolchildren in Rural China: A Cluster-Randomized Controlled Trial

“…Lastly, there is "very limited evidence assessing an effect on school attendance and the findings are inconsistent and at risk for bias" (20,243 participants, in two trials and with very low-quality evidence. In addition to the high risks of recruitment bias noted by the authors of the Cochrane study, the current evidence base is limited by the following characteristics of existing studies: many trials are conducted with small sample sizes and are underpowered 13,14 ; many trials measure only one or two specific outcomes, often with selective reporting of outcomes 12,14,15 ; and many trials do not report infection intensity, 12 which is measured by fecal egg counts, and which (if intensities are high or low) may have implications for the nature of the impact being measured. Furthermore, the majority of existing trials have been efficacy studies of individualized treatment, which tend to be researcher-implemented in a highly controlled setting.…”

Fascioliasis and Eosinophilia in the Highlands of Cuzco, Peru and Their Association with Water and Socioeconomic Factors

“…In addition, the impact of preventive chemotherapy for fascioliasis on anemia and malnutrition should be evaluated before implementation. 19,20 We noted an association between giardiasis and having Fasciola eggs in the stool. Esteban and others 21,22 also noted this association in studies in high prevalence areas of the Peruvian and Bolivian Altiplano.…”